vimarsana.com

Page 6 - க்க்ஸ் கையகப்படுத்தல் கார்ப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SHAREHOLDER ALERT: WeissLaw LLP Reminds LCY, PROS, IPHI, and GXGX Shareholders About Its Ongoing Investigations

SHAREHOLDER ALERT: WeissLaw LLP Reminds NK, XLNX, GXGX, and ACEV Shareholders About Its Ongoing Investigations

SHAREHOLDER ALERT: Rigrodsky Law, P A Reminds Investors of Investigations of ANCN, JWS, GXGX,

Press release content from Globe Newswire. The AP news staff was not involved in its creation. SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of ANCN, JWS, GXGX, . Rigrodsky Law, P.AJanuary 26, 2021 GMT WILMINGTON, Del., Jan. 26, 2021 (GLOBE NEWSWIRE) Rigrodsky Law, P.A. announces that it is investigating: Anchiano Therapeutics Ltd. (NASDAQ GS: ANCN ) regarding possible breaches of fiduciary duties and other violations of law related to Anchiano Therapeutics’ agreement to merge with Chemomab Ltd. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-anchiano-therapeutics-ltd. ADVERTISEMENT Jaws Acquisition Corp. (NYSE: JWS ) regarding possible breaches of fiduciary duties and other violations of law related to Jaws Acquisition’s agreement to merge with Cano Health, LLC. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-jaws-acquisition-corp.

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of GX Acquisition Corp

Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating GX Acquisition Corp. ( GXGX or the Company ) ( ) relating to its proposed merger with Celularity, Inc. Under the terms of the agreement, GXGX will acquire Celularity through a reverse merger, with Celularity emerging as a publicly traded company. The investigation focuses on whether GX Acquisition Corp. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, 2) whether the transaction is properly valued and 3) whether all material information has been disclosed.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.